Cargando…
Universal molecular screening does not effectively detect Lynch syndrome in clinical practice
BACKGROUND: Lynch syndrome (LS) due to an inherited damaging mutation in mismatch repair (MMR) genes comprises 3% of all incident colorectal cancer (CRC). Molecular testing using immunohistochemistry (IHC) for MMR proteins is a recommended screening tool to identify LS in incident CRC. This study as...
Autores principales: | Brennan, Beatrice, Hemmings, Christine T., Clark, Ian, Yip, Desmond, Fadia, Mitali, Taupin, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405883/ https://www.ncbi.nlm.nih.gov/pubmed/28491141 http://dx.doi.org/10.1177/1756283X17690990 |
Ejemplares similares
-
The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma
por: Wang, Aifen, et al.
Publicado: (2018) -
Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort
por: Subramaniam, Kavitha, et al.
Publicado: (2019) -
Screening and identification of Lynch syndrome: a systematic review of the frequency of Lynch syndrome-associated clinicopathologic and molecular characteristics in Lynch syndrome gynecologic cancers
por: Yang, Zihui, et al.
Publicado: (2021) -
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting
por: Kanjanapan, Yada, et al.
Publicado: (2023) -
Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative
por: Spinosa, Daniel, et al.
Publicado: (2021)